Taku Uchida1,2, Christoph Lossin3, Yukiko Ihara4, Masanobu Deshimaru5, Yuchio Yanagawa6, Susumu Koyama7, Shinichi Hirose2,4 (1.Department of Neuroscience, Section of Integrative Physiology, Faculty of Medicine, University of Miyazaki, Japan, 2.Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University, Japan, 3.Department of Neurology, University of California, Davis, USA, 4.Department of Pediatrics, Fukuoka University School of Medicine, Japan, 5.Department of Chemistry, Faculty of Science, Fukuoka University, Japan, 6.Department of Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Japan, 7.Department of Advanced Pharmacology, Daiichi University of Pharmacy, Japan)
Session information
ISS
[ISS-O2] Abstract 2
Sat. Jun 1, 2019 10:45 AM - 11:05 AM ISS Conference Room (Internatinal Conference Room, 3F, Bldg. 3)
Chair: Shin-ichiro Hamano (Saitama Children's Medical Center, Japan)
Ozlem Yayici Koken1, Ozge Dedeoglu Toptas1, Busra Cavdarli2, Ayse Aksoy1 (1.SBU, Dr Sami Ulus Research and Training Hospital, Ankara, Turkey, 2.Ankara Numune Education and Training Hospital, Ankara, Turkey)